1![Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers Jerome Mauris1, Flavio Mantelli1¤a, Ashley M. Woodward1, Ziyhi Cao2, Caro Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers Jerome Mauris1, Flavio Mantelli1¤a, Ashley M. Woodward1, Ziyhi Cao2, Caro](https://www.pdfsearch.io/img/2c12f436f5bcb140478ea17dfbabc133.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
2![Archives of Biochemistry and Biophysics Vol. 383, No. 2, November 15, pp. 157–170, 2000 doi:abbi, available online at http://www.idealibrary.com on Differences in Zero-Force and Force-Driven Kinetics Archives of Biochemistry and Biophysics Vol. 383, No. 2, November 15, pp. 157–170, 2000 doi:abbi, available online at http://www.idealibrary.com on Differences in Zero-Force and Force-Driven Kinetics](https://www.pdfsearch.io/img/4eccfaf5f2b11c48fad1da3657e392eb.jpg) | Add to Reading ListSource URL: www.biophysik.physik.uni-muenchen.deLanguage: English - Date: 2015-11-10 10:48:39
|
---|
3![Classification and Motif Extraction of Glycans in Bloods Yoshiyuki Hizukuri1 Yoshihiro Yamanishi1 Osamu Nakamura2 Classification and Motif Extraction of Glycans in Bloods Yoshiyuki Hizukuri1 Yoshihiro Yamanishi1 Osamu Nakamura2](https://www.pdfsearch.io/img/0dcc48f5bbb0065ccff3601436c35837.jpg) | Add to Reading ListSource URL: www.jsbi.orgLanguage: English - Date: 2005-01-18 03:44:17
|
---|
4![Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and its Novel Galectin-3 inhibitor in Development for Idiopathic Pulmonary Fibrosis (NEW YORK and COPENHAGEN – November 3, Bri Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and its Novel Galectin-3 inhibitor in Development for Idiopathic Pulmonary Fibrosis (NEW YORK and COPENHAGEN – November 3, Bri](https://www.pdfsearch.io/img/244d867b0e23e28c75458879ca330edb.jpg) | Add to Reading ListSource URL: sunstone.eu- Date: 2014-11-03 07:57:22
|
---|
5![Synthetic inhibitors of galectin-1 and -3 sel... [Anticancer Resdi 1 Display Settings: Synthetic inhibitors of galectin-1 and -3 sel... [Anticancer Resdi 1 Display Settings:](https://www.pdfsearch.io/img/b1c751b85f36526ced9adc46db5c0eb2.jpg) | Add to Reading ListSource URL: www.cinbo.orgLanguage: English - Date: 2012-12-21 09:31:05
|
---|
6![Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment](https://www.pdfsearch.io/img/874780a9f26974a695ae85ad404f95f2.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2010-11-18 09:32:27
|
---|
7![Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death](https://www.pdfsearch.io/img/cd9214b3aa7a271b2bf790ebf114711c.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2010-02-04 08:58:19
|
---|
8![A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells](https://www.pdfsearch.io/img/486ff456d7df93554e34585af908a247.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2012-01-12 05:57:43
|
---|
9![The glycan-binding protein galectin-1 controls survival of epithelial cells along the crypt-villus axis of small intestine The glycan-binding protein galectin-1 controls survival of epithelial cells along the crypt-villus axis of small intestine](https://www.pdfsearch.io/img/45a09bae215c0d63a8f89797e3221ab5.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English |
---|
10![(Significantly Regulated) Listing of U.S. Industries for Filing Year 2014 Company Galectin Therapeutics Inc. Galena Biopharma, Inc. Gelstat Corporation Geltech Solutions, Inc. (Significantly Regulated) Listing of U.S. Industries for Filing Year 2014 Company Galectin Therapeutics Inc. Galena Biopharma, Inc. Gelstat Corporation Geltech Solutions, Inc.](https://www.pdfsearch.io/img/1b9742599155d3baca30289f4baa451a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|